COLO B — Coloplast A/S Income Statement
0.000.00%
Last trade - 00:00
- DKK190.03bn
- DKK213.65bn
- DKK24.50bn
- 65
- 10
- 46
- 32
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17,939 | 18,544 | 19,426 | 22,579 | 24,500 |
Cost of Revenue | |||||
Gross Profit | 12,153 | 12,612 | 13,313 | 15,529 | 16,328 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12,783 | 12,690 | 13,271 | 16,140 | 17,729 |
Operating Profit | 5,156 | 5,854 | 6,155 | 6,439 | 6,771 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5,028 | 5,466 | 6,233 | 6,127 | 6,025 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,873 | 4,197 | 4,825 | 4,706 | 4,783 |
Net Income Before Extraordinary Items | |||||
Net Income | 3,873 | 4,197 | 4,825 | 4,706 | 4,783 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3,873 | 4,197 | 4,825 | 4,706 | 4,783 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 19.8 | 19.7 | 23.4 | 23.8 | 22.5 |
Dividends per Share |